Events | Financial News | News

Strategy update: IDL Diagnostics

Nov 28, 2025

A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their presentation, Redeye analyst Oscar Bergman moderated a Q&A session.

See the presentation here

IDL Diagnostics and concile at WHX Labs Dubai

Feb 20, 2026 | ,

Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection,...

read more

Meet us at WHX Labs Dubai 10-13 February

Feb 2, 2026 | ,

We will be co-exhibiting together with our partner concile at Booth SA.A55. Come by our booth and learn more about our products and how quantitative point-of-care testing can be used to provide accurate and rapid results.

read more